Amara Diallo
Science Communicator
Amara writes the pieces meant for a reader's first five minutes on the site. Her background is in public science communication, translating lab findings for general audiences.
FDA Widens Approval for Anktiva in Bladder Cancer
FDA expanded approval of nogapendekin alfa inbakicept combined with BCG to more bladder cancer patients, per an FDA drug announcement.
Afamelanotide Research Overview: What Studies Show About This Photoprotective Melanocortin Peptide
A look at what published research actually shows about afamelanotide, its mechanism, and its approved use in porphyria.
Pilot Study Tracks Body Composition During GLP-1 Therapy Plus Exercise
A retrospective pilot study looks at fat versus lean mass changes when incretin based weight loss drugs are paired with exercise and nutrition coaching.
Cagrilintide Research Overview: What Studies Show About This Amylin Analog
A plain look at what clinical trials actually show about cagrilintide, an amylin analog studied alone and paired with semaglutide.
Case Series Links Tirzepatide to Recurring Eyelid Bumps
A small case series describes patients on tirzepatide developing repeated styes and chalazia, though a causal link remains unproven.
DSIP: Delta Sleep Inducing Peptide Research Review
DSIP was isolated from rabbit brain in 1977 to explain deep sleep, but decades of trials have never agreed on what it actually does.
Tirzepatide Explored in Rare Post Bypass Hypoglycemia Cases
A three patient case report looks at tirzepatide for low blood sugar after gastric bypass surgery.
FDA Warns Tex Peptides Over Unapproved Drug Claims
FDA warning letter cites Tex Peptides for marketing semaglutide, tirzepatide and other peptides as unapproved drugs.
How Peptides Work in the Body
Peptides are short amino acid chains that bind specific receptors and break down quickly, which shapes how they are studied and given.